Although we did not detect any differentially methylated loci at the SMARCB1 locus on chromosome 22, we did observe an enrichment of SCT-associated DMPs at 15 CpG sites previously associated with clear cell renal carcinoma (a more common type of kidney cancer) [81]. This evidence concerns the gene SMARCB1 and kidney cancer.